Clinical trial
Safety of the Buprenorphine Transdermal Delivery System in Subjects With…
NCT00315835 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00315835 |
|---|---|
| Title | Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery. |
| Official title | A Single Dose, Randomized, Double-Blind, Parallel Group Study of the Safety and Pharmacokinetics of Buprenorphine TDS (12.5, 25, 50 Mcg/Hour) Vs. Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal delivery system |
| Enrollment | 100 |
| Start date | Oct 1, 1996 |
| Completion | Nov 1, 1997 |
| First posted | Apr 19, 2006 |
| Last update posted | Apr 19, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: